Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jun 9.
Published in final edited form as: Am J Cardiol. 2011 Feb 23;107(8):1246–1249. doi: 10.1016/j.amjcard.2010.12.022

Relation of Vitamin D Level to Maximal Oxygen Uptake in Adults

Afrooz Ardestani a, Beth Parker a, Shishir Mathur a, Priscilla Clarkson b, Linda S Pescatello c, Heather Hoffman d, Donna Polk a, Paul D Thompson a
PMCID: PMC4460985  NIHMSID: NIHMS277383  PMID: 21349488

Abstract

Both low cardiorespiratory fitness and low serum vitamin D levels are associated with increased cardiovascular and all-cause mortality, but whether low vitamin D is independently associated with cardiorespiratory fitness in healthy adults is not known. We examined vitamin D levels and fitness in 200 healthy adults, participating in a double-blind clinical trial investigating statins and muscle performance (the STOMP study). Maximal aerobic exercise capacity (VO2max) was measured using metabolic gas analysis during graded treadmill exercise to exhaustion. Vitamin D [25(OH)D] was measured using enzyme-linked immunosorbent assay (ELISA). Daily physical activity was assessed using the Paffenbarger Physical Activity Questionnaire. Serum 25(OH)D concentration was positively related to VO2max (r =0.29, p=0.0001), even after adjusting for relevant predictors (e.g., age, gender and body mass index) (p= 0.0004). There was also a significant interaction between 25(OH)D level and self-reported hours of moderate to vigorous physical activity (MVPA) (p<0.02). With each standard deviation increase in vitamin D, VO2max increased by 2.6 ml/kg/min (p=0.0001) when MVPA was low (16 hr/wk), 1.6 ml/kg/min (p=0.0004) when MVPA was moderate (35 hr/wk), but only 0.07 ml/kg/min (p=0.9) when MVPA was high (64 hr/wk). In conclusion, serum vitamin D levels predict VO2max in adults; the effect is greatest among those with low levels of physical activity.

Keywords: Vitamin D level, VO2max


Vitamin D deficiency is present in approximately 50% of US adults 1,2 and is associated with increased cardiovascular (CV) events and overall mortality.3,4,5 Vitamin D deficiency may affect CV morbidity and mortality via its effect on cardiovascular risk factors, such as elevated blood pressure and the incidence of Type II diabetes.6,7,8 Poor cardiorespiratory fitness is an additional independent risk factor for CV morbidity and mortality, 9,10 and cardiorespiratory fitness, measured as maximal oxygen consumption or VO2max, has recently been shown to be directly related to serum vitamin D in 59 healthy young women. 11 The present study examined the relationship of vitamin D levels to cardiorespiratory fitness in a larger cohort of men and women.

Methods

Baseline data were collected on 200 adults free of overt cardiovascular and metabolic disease, who were participating in a double-blind, clinical trial investigating the effect of statins on skeletal muscle performance (STOMP study).12 Subjects were not taking medications known to affect serum lipids, blood pressure or muscle metabolism. Prior to statin or placebo treatment, subjects completed three study visits over a period of 2 weeks. Participants underwent a modified Balke treadmill test to determine VO2max.13 VO2max and ventilatory threshold were determined using breath-by-breath analysis of expired gases with a Parvomedics TrueOne 2400 metabolic cart (ParvoMedics Corp., Sandy, UT). Subjects fasted for 8–12 hours before the test. Attainment of VO2max was affirmed when subjects met 3 of 4 criteria: plateau of oxygen uptake (defined as < 50 mL/min increase with a 1% increase in treadmill grade), attainment ± 10 bpm of age-predicted maximal heart rate, volitional exhaustion (defined as a rating of perceived exertion ≥18) and calculated respiratory exchange ratio >1.10. 14

Subjects’ daily physical activity levels at baseline were documented using the Paffenbarger Physical Activity Questionnaire (PPAQ). 15 Subjects reported their average hours of physical activity over the course of the week to identify hours of sedentary, light, moderate and vigorous activities (Question #8, PPAQ). Vigorous activities were defined as any strenuous sports, jogging, aerobic exercise, bicycling on hills and similar activities. Moderate activities were defined as lighter sports, regular walking, golf, house and yard work. Total hours of moderate to vigorous physical activity per week (MVPA) were used to examine the relationship between vitamin D, cardiorespiratory fitness and daily physical activity. Body weight was measured using a calibrated balance beam scale. Height was determined using a wall mounted tape measure. Serum 25(OH)D, which measures combined serum vitamin D2 and D3, was determined using blood collected at the first study visit, using a standard ELISA immunoassay protocol (Clinical Laboratory Partners, Newington, Connecticut). The seasons in which the vitamin D level was measured were recorded to account for potential seasonal variation in vitamin D levels. The seasons were defined as: winter (December–February); spring (March–May); summer (June–August); and fall (September–November).

The response variable of interest was cardiorespiratory fitness (VO2max). The independent variables included age, MVPA, 25(OH)D, body mass index, gender, cigarette smoking, and season. Means and standard deviations were calculated for all continuous variables; frequencies and percentages were reported for all categorical variables. Bivariable associations were assessed using simple linear regression and t-tests. Analysis of covariance (ANCOVA) was used to evaluate the relationship between VO2max and serum vitamin D level after controlling for clinically and statistically significant predictors. Two-way interactions between the predictors were considered in our ANCOVA models. All analyses were performed using SAS version 9.1.3 (SAS Institute, Cary, North Carolina).

Results

Data from 200 healthy adults were analyzed, of whom 108 (54%) were women and 22 (11%) were chronic smokers (Table 1). Vitamin D levels were directly related to VO2max (r=0.29, p<0.0001) (Figure 1). VO2max was also significantly correlated with age (r= −0.58, p<0.0001) and body mass index (r= −0.24, p=0.0005). We also compared the mean VO2max levels among vitamin D deficient (25(OH)D<20 ng/ml, n=29, 15%), insufficient (25(OH)D=20–30 ng/ml, n=52, 26%) or sufficient (25(OH)D >30 ng/ml, n=119, 59%) groups and documented higher VO2max values in the sufficient group (Figure 2). 7,8 The relationship between vitamin D level and VO2max remained statistically significant even after adjusting for gender (p=0.001), age(p=0.0001), BMI (p=0.0001) and MVPA(p=0.05). Seasonal variation (p=0.7) and tobacco use (p=0.2) were not significantly associated with VO2max. There was also a statistically significant interaction between vitamin D level and MVPA (p <0.02), indicating that the effect of vitamin D level on VO2max is modified by the hours of MVPA. Consequently, we reanalyzed the effect of vitamin D on VO2max by percentiles of physical activity. The mean hours of MVPA at the 25th (<23 hr/wk, n=49), 25–75th (23–48 hr/wk, n=103) and 75th (>48 hr/wk, n=48) percentiles were 16, 35 and 64 hr/wk, respectively. Including these mean values in the model showed that for each standard deviation (SD) (13 units) increase in vitamin D, VO2max increased by 2.6ml/kg/min (p<0.0001) when MVPA was low, 1.6 ml/kg/min (p<0.0004) when MVPA was moderate and only 0.01 ml/kg/min (p=0.9) when MVPA was high (Figure 3).

Table 1.

Subject (N=200) Baseline Characteristics

Variable Total
Mean ± SD
Male (n=92)
Mean ± SD
Female (n=108)
Mean ± SD
p-value
VO2max (ml/kg/min) 34 ±10.3 40 ±9.1 30 ±8.5 < 0.01
Age (years) 40 ±14.4 39 ±15.2 42 ±13.9 0.12
25(OH) D (ng/ml) 34 ±13.3 33 ±11.3 35 ±14.6 0.44
Waist circumference(cm) 85 ±13.7 92 ±12.2 80 ±11.9 < 0.01
BMI (kg/m²) 26 ±5.1 27 ±4.5 26 ±5.3 0.01
MVPA (hrs/wk) 37±19 36 ±17.0 38 ±20.0 0.56
Season [25(OH)D measurement]
 Spring 71 (35%) 31(34%) 40(37%) 0.7
 Summer 53 (26%) 27(29%) 26(24%)
 Fall 30 (15%) 15(16%) 15(14%)
 Winter 46 (23%) 19(21%) 27(25%)

25(OH) D = Serum 25-hydroxy vitamin D, BMI = body mass index, MVPA = hours of moderate to vigorous physical activity per week, SD = Standard Deviation, VO2max = Maximal oxygen uptake. P-value for gender difference.

Figure 1.

Figure 1

The simple linear regression equation and 95% prediction bands for the regression of serum 25(OH)D with maximal oxygen uptake (VO2max) (N=200, crude r=0.29, p<0.0001).

Figure 2.

Figure 2

Comparison of mean VO2max (shown within bar graphs with the corresponding standard error) among vitamin D deficient (25(OH)D <20 ng/ml), insufficient (25(OH)D, 20–30 ng/ml) and sufficient (25(OH)D >30 ng/ml) subjects.

Figure 3.

Figure 3

The relationship between 25 (OH) vitamin D [25 (OH) D] and maximal oxygen uptake (VO2 max) by percentiles and mean hours of moderate to vigorous physical activity (MVPA) for the low (25th, 16 hrs/wk), moderate (25th–75th, 35 hrs/wk) and high (75th, 64 hrs/wk) groups.

Discussion

This study is to our knowledge the first large cross sectional study of the relationship between vitamin D levels and aerobic cardiorespiratory fitness. We documented that vitamin D is positively associated with cardiorespiratory fitness in healthy adults independent of their age, gender and body mass index. Moreover, this relationship of vitamin D levels and aerobic exercise performance was more prominent among those subjects who did not engage in substantial amounts of moderate to vigorous physical activity.

There has been little published on the relationship between cardiorespiratory fitness and serum 25 (OH) D levels. Mowry et al. examined the association of baseline cardiorespiratory fitness (VO2max) with 25[OH]D in 59 young healthy women, aged 16 to 24 years.11 There was a positive association between VO2 max and serum 25(OH)D (r = 0.36 p<0.05). The present study confirms a direct relationship between vitamin D levels and VO2 max (r =0.29, p< 0.0001), in both men and women over a broad age range of age (20 to 73 years) and serum 25(OH)D levels (10 to 82 ng/ml. The positive relationship between vitamin D levels and VO2max persisted after adjustment for age, gender, body mass index, and MVPA, especially among individuals with low levels of physical activity. This suggests that Vitamin D contributes to cardiorespiratory fitness.

An alternative explanation is that cardiorespiratory fitness is simply a surrogate for an individual’s daily physical activity, which could be related to light exposure and therefore to vitamin D. To explore this hypothesis, we examined the interaction of MVPA and seasonal variation to the relationship between vitamin D and VO2max. Despite the higher daily physical activity and serum 25(OH)D level observed during the warmer months, seasonal variations in vitamin D did not affect VO2max or the VO2 max – vitamin D relationship.

We did find an interaction of 25(OH)D level with the amount of physical activity such that individuals with the lowest level of MVPA demonstrated the strongest relationship between vitamin D and VO2max. For example, each SD increase in 25(OH)D level increased VO2max by 8% (with percent change calculated relative to the group average) among those with the lowest level of MVPA. Notably, this effect size is comparable to the change in VO2max observed with mild to moderate intensity exercise training. 16 One SD increase in serum 25(OH)D also increased VO2max by 5% among those with moderate level of MVPA, but only by 0.2% among those with high level of MVPA (Figure 3).

The mechanism for the interactive effect of vitamin D and MVPA on cardiorespiratory fitness is not clear. VO2max is limited by cardiac output, arterial oxygen content, shunting of blood to active muscle and the extraction of oxygen by these muscles. Low serum 25(OH)D levels can cause myocardial hypertrophy, elevated blood pressure and endothelial dysfunction via vitamin D receptors 7,8,17,18,19 Consequently, low vitamin D levels may decrease cardiac output and increase peripheral vessel resistance reducing VO2 max. Physical activity is also known to increase VO2max through increased cardiac output. 16,20,21 Results from a large healthy adult cohort study suggest that the greatest benefits of physical activity on cardiac remodeling occur at the lowest levels of reported physical activity. 22 Therefore, vitamin D could potentially have a greater benefit on cardiac remodeling and VO2max among individuals with low levels of physical activity than among those who already engage in high levels of activity. There is also evidence that both physical inactivity 23,24 and vitamin D deficiency 25,26,27can cause muscle atrophy and shift muscle fiber type from IIa to IIb. Therefore, it is possible that individuals with the lowest level of physical activity receive a greater aerobic benefit from increasing vitamin D levels via changes in muscle mass and fiber type than those who already engage in high levels of physical activity. Alternatively, less active subjects in our study had a higher BMI (p<0.007) and waist circumference (p<0.02). This could indicate a clustering of other cardiovascular risk factors such as insulin resistance, high blood pressure and arterial stiffness, which could augment the negative effect of low vitamin D on VO2max among sedentary individuals.28

There are several limitations to this study. We did not record the amount of vitamin D taken by supplemental or dietary means. However, serum 25(OH)D level is reflective of all vitamin D sources and is the benchmark for determining vitamin D status. In addition, other biomarkers related to vitamin D, such as serum parathyroid hormone, calcium and phosphorus levels were not analyzed and could contribute to the relationship between exercise performance and vitamin D. Furthermore, physical activity was measured by self report and subject to recall bias, although The Paffenbarger Questionnaire has been well validated. 29

Acknowledgments

This study was supported by National Heart, Lung and Blood Institute (NHLBI) R01 HL081893.

The authors thank Stephanie Moeckel Cole and Justin Keadle for their valuable contributions.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. 2005;15:S5-97–101. [PubMed] [Google Scholar]
  • 2.Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771–777. doi: 10.1016/s8756-3282(02)00692-0. [DOI] [PubMed] [Google Scholar]
  • 3.Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–1180. doi: 10.1001/archinte.168.11.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–1349. doi: 10.1001/archinte.168.12.1340. [DOI] [PubMed] [Google Scholar]
  • 5.Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730–1737. doi: 10.1001/archinte.167.16.1730. [DOI] [PubMed] [Google Scholar]
  • 6.Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159–1165. doi: 10.1001/archinte.167.11.1159. [DOI] [PubMed] [Google Scholar]
  • 7.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281. doi: 10.1056/NEJMra070553. [DOI] [PubMed] [Google Scholar]
  • 8.Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol. 2009;7:414–422. doi: 10.2174/157016109788340686. [DOI] [PubMed] [Google Scholar]
  • 9.Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973;85:546–562. doi: 10.1016/0002-8703(73)90502-4. [DOI] [PubMed] [Google Scholar]
  • 10.Lyerly GW, Sui X, Lavie CJ, Church TS, Hand GA, Blair SN. The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc. 2009;84:780–786. doi: 10.4065/84.9.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mowry DA, Costello MM, Heelan KA. Association among cardiorespiratory fitness, body fat, and bone marker measurements in healthy young females. J Am Osteopath Assoc. 2009;109:534–539. [PubMed] [Google Scholar]
  • 12.Thompson PD, Parker BA, Clarkson PM, Pescatello LS, White CM, Grimaldi AS, Levine BD, Haller RG, Hoffman EP. A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. Prev Cardiol. 13:104–111. doi: 10.1111/j.1751-7141.2009.00063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Whaley ME, Brubaker PH, Otto RM, editors. American College of Sports Medicine AsGfETaPtE. Philadelphia, PA: Lippincott Williams and Wilkins; 2006. pp. 99–102. [Google Scholar]
  • 14.Howley ET, Bassett DR, Jr, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc. 1995;27:1292–1301. [PubMed] [Google Scholar]
  • 15.Paffenbarger RS, Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978;108:161–175. doi: 10.1093/oxfordjournals.aje.a112608. [DOI] [PubMed] [Google Scholar]
  • 16.Gormley SE, Swain DP, High R, Spina RJ, Dowling EA, Kotipalli US, Gandrakota R. Effect of intensity of aerobic training on VO2max. Med Sci Sports Exerc. 2008;40:1336–1343. doi: 10.1249/MSS.0b013e31816c4839. [DOI] [PubMed] [Google Scholar]
  • 17.Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41:105–112. doi: 10.1016/s0735-1097(02)02624-4. [DOI] [PubMed] [Google Scholar]
  • 18.Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–238. doi: 10.1172/JCI15219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mitsuhashi T, Morris RC, Jr, Ives HE. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest. 1991;87:1889–1895. doi: 10.1172/JCI115213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bassett DR, Jr, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32:70–84. doi: 10.1097/00005768-200001000-00012. [DOI] [PubMed] [Google Scholar]
  • 21.Mitchell JH, Blomqvist G. Maximal oxygen uptake. N Engl J Med. 1971;284:1018–1022. doi: 10.1056/NEJM197105062841809. [DOI] [PubMed] [Google Scholar]
  • 22.Turkbey EB, Jorgensen NW, Johnson WC, Bertoni AG, Polak JF, Roux AV, Tracy RP, Lima JA, Bluemke DA. Physical activity and physiological cardiac remodelling in a community setting: the Multi-Ethnic Study of Atherosclerosis (MESA) Heart. 96:42–48. doi: 10.1136/hrt.2009.178426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Haggmark T, Eriksson E. Hypotrophy of the soleus muscle in man after achilles tendon rupture. Discussion of findings obtained by computed tomography and morphologic studies. Am J Sports Med. 1979;7:121–126. doi: 10.1177/036354657900700208. [DOI] [PubMed] [Google Scholar]
  • 24.Andersen P, Henriksson J. Training induced changes in the subgroups of human type II skeletal muscle fibres. Acta Physiol Scand. 1977;99:123–125. doi: 10.1111/j.1748-1716.1977.tb10361.x. [DOI] [PubMed] [Google Scholar]
  • 25.Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19:265–269. doi: 10.1359/jbmr.2004.19.2.265. [DOI] [PubMed] [Google Scholar]
  • 26.Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev. 1986;7:434–448. doi: 10.1210/edrv-7-4-434. [DOI] [PubMed] [Google Scholar]
  • 27.Sorensen OH, Lund B, Saltin B, Andersen RB, Hjorth L, Melsen F, Mosekilde L. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) 1979;56:157–161. doi: 10.1042/cs0560157. [DOI] [PubMed] [Google Scholar]
  • 28.Whaley MH, Kampert JB, Kohl HW, 3rd, Blair SN. Physical fitness and clustering of risk factors associated with the metabolic syndrome. Med Sci Sports Exerc. 1999;31:287–293. doi: 10.1097/00005768-199902000-00013. [DOI] [PubMed] [Google Scholar]
  • 29.Ainsworth BE, Leon AS, Richardson MT, Jacobs DR, Paffenbarger RS., Jr Accuracy of the College Alumnus Physical Activity Questionnaire. J Clin Epidemiol. 1993;46:1403–1411. doi: 10.1016/0895-4356(93)90140-v. [DOI] [PubMed] [Google Scholar]

RESOURCES